Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer
Cell Reports · 2024-07 · 43 (7) · 114487
DOI: 10.1016/j.celrep.2024.114487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-07. Verfasst von Hongmiao Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China; Ke…. Hauptthemen laut MEDLINE: Sorafenib, Liver Neoplasms, Drug Resistance, Neoplasm, Ubiquitin-Specific Proteases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
The integrated stress response (ISR) is activated in response to intrinsic and extrinsic stimuli, playing a role in tumor progression and drug resistance. The regulatory role and mechanism of ISR in liver cancer, however, remain largely unexplored. Here, we demonstrate that OTU domain-containing protein 3 (OTUD3) is a deubiquitylase of eukaryotic initiation factor 2α (eIF2α), antagonizing ISR and suppressing liver cancer. OTUD3 decreases interactions between eIF2α and the kinase EIF2ΑK3 by removing K27-linked polyubiquitylation on eIF2α. OTUD3 deficiency in mice leads to enhanced ISR and accelerated progression of N-nitrosodiethylamine-induced hepatocellular carcinoma. Additionally, decreased OTUD3 expression associated with elevated eIF2α phosphorylation correlates with the progression of human liver cancer. Moreover, ISR activation due to decreased OTUD3 expression renders liver cancer cells resistant to sorafenib, while the combined use of the ISR inhibitor ISRIB significantly improves their sensitivity to sorafenib. Collectively, these findings illuminate the regulatory mechanism of ISR in liver cancer and provide a potential strategy to counteract sorafenib resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China; Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomac…
- State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China.
- State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China; School of Medicine, Tsinghua University, Beijing 100084, China.
- State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China; Department of Pathology and Pathophysiology, School of Basic Medical Sci…
- State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China; Department of Cell Biology, School of Basic Medicine, Medical College, Q…
- State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China; School of Life Sciences, Hebei University, Baoding, Hebei 071002, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Dai, H., Wu, B., Ge, Y., Hao, Y., Zhou, L., Hong, R., Zhang, J., Jiang, W., Zhang, Y., Li, H., & Zhang, L. (2024). Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer. Cell Reports, 43(7), 114487. https://doi.org/10.1016/j.celrep.2024.114487
Vancouver
Dai H, Wu B, Ge Y, Hao Y, Zhou L, Hong R, et al. Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer. Cell Reports. 2024;43(7):114487. doi:10.1016/j.celrep.2024.114487
BibTeX
@article{Dai2024,
author = {Dai, Hongmiao and Wu, Bo and Ge, Yingwei and Hao, Yang and Zhou, Lijie and Hong, Ruolin and Zhang, Jinhao and Jiang, Wenli and Zhang, Yuting and Li, Hongchang and Zhang, Lingqiang},
title = {Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {7},
pages = {114487},
doi = {10.1016/j.celrep.2024.114487}
}
EUVIMED